Congxiang Shao

529 total citations
23 papers, 333 citations indexed

About

Congxiang Shao is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Congxiang Shao has authored 23 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 14 papers in Hepatology and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Congxiang Shao's work include Liver Disease Diagnosis and Treatment (21 papers), Liver Disease and Transplantation (13 papers) and Diet, Metabolism, and Disease (11 papers). Congxiang Shao is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Liver Disease and Transplantation (13 papers) and Diet, Metabolism, and Disease (11 papers). Congxiang Shao collaborates with scholars based in China, United States and Canada. Congxiang Shao's co-authors include Junzhao Ye, Fuxi Li, Bihui Zhong, Yansong Lin, Shi‐Ting Feng, Wei Wang, Bihui Zhong, Qianqian Ma, Yanhong Sun and Yanqin Wu and has published in prestigious journals such as American Journal of Clinical Nutrition, Nutrients and Digestive Diseases and Sciences.

In The Last Decade

Congxiang Shao

20 papers receiving 332 citations

Peers

Congxiang Shao
Bihui Zhong China
Marta Flisiak‐Jackiewicz Poland
Erika Paolini Italy
Luis Miguel Vazquez‐Montesino United States
Cristina Muzîca Romania
Silvia Sabatini Italy
Jacob George Australia
Mary P. Moore United States
Kristina Önnerhag Sweden
Mauro Maurantonio Italy
Bihui Zhong China
Congxiang Shao
Citations per year, relative to Congxiang Shao Congxiang Shao (= 1×) peers Bihui Zhong

Countries citing papers authored by Congxiang Shao

Since Specialization
Citations

This map shows the geographic impact of Congxiang Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Congxiang Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Congxiang Shao more than expected).

Fields of papers citing papers by Congxiang Shao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Congxiang Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Congxiang Shao. The network helps show where Congxiang Shao may publish in the future.

Co-authorship network of co-authors of Congxiang Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Congxiang Shao. A scholar is included among the top collaborators of Congxiang Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Congxiang Shao. Congxiang Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Junzhao, Jiaming Lai, Xiaodong Zhuang, et al.. (2025). Machine Learning Models for Screening Steatosis in MASLD : An International Validation Study. Liver International. 45(12). e70416–e70416.
2.
Shao, Congxiang, Teng Long, Shuyu Zhuo, et al.. (2025). Liver fibrosis with persistently normal alanine transaminase levels exhibits a distinct treatment response in MASLD. BMJ Open Gastroenterology. 12(1). e001895–e001895.
3.
Shao, Congxiang, Junzhao Ye, Zhi Dong, et al.. (2024). Phospholipid metabolism-related genotypes of PLA2R1 and CERS4 contribute to nonobese MASLD. Hepatology Communications. 8(6).
4.
Ye, Junzhao, Sui-Lin Mo, Xiaoyi Li, et al.. (2024). Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians. Journal of Gastroenterology and Hepatology. 39(8). 1636–1647. 5 indexed citations
5.
Shao, Congxiang, et al.. (2023). Metabolomics to identify fingerprints of carotid atherosclerosis in nonobese metabolic dysfunction-associated fatty liver disease. Journal of Translational Medicine. 21(1). 12–12. 11 indexed citations
6.
Lin, Yansong, Shuyu Zhuo, Zhi Dong, et al.. (2023). Treatment of obesity and metabolic-associated fatty liver disease with a diet or orlistat: A randomized controlled trial. American Journal of Clinical Nutrition. 117(4). 691–700. 15 indexed citations
7.
Shao, Congxiang, Junzhao Ye, Yansong Lin, et al.. (2022). Discrepancies between Nonalcoholic and Metabolic-associated Fatty Liver Disease by Multiple Steatosis Assessment. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 4 indexed citations
8.
Ye, Junzhao, Congxiang Shao, Yansong Lin, et al.. (2022). Vitamin D Status Presents Different Relationships with Severity in Metabolic-Associated Fatty Liver Disease Patients with or without Hepatitis B Infection. Nutrients. 14(10). 2114–2114. 4 indexed citations
9.
Ma, Qianqian, Congxiang Shao, Yansong Lin, et al.. (2022). Lipid-Lowering Responses to Dyslipidemia Determine the Efficacy on Liver Enzymes in Metabolic Dysfunction-Associated Fatty Liver Disease with Hepatic Injuries: A Prospective Cohort Study. Diabetes Metabolic Syndrome and Obesity. Volume 15. 1173–1184. 7 indexed citations
10.
Ye, Junzhao, Xiaorong Gong, Xin Li, et al.. (2021). Apolipoproteins and liver parameters optimize cardiovascular disease risk-stratification in nonalcoholic fatty liver disease. Digestive and Liver Disease. 53(12). 1610–1619. 6 indexed citations
11.
Ma, Qianqian, Congxiang Shao, Yansong Lin, et al.. (2021). Normalization of γ-glutamyl transferase levels is associated with better metabolic control in individuals with nonalcoholic fatty liver disease. BMC Gastroenterology. 21(1). 215–215. 12 indexed citations
12.
Lin, Yansong, Xiaorong Gong, Xin Li, et al.. (2021). Distinct Cause of Death Profiles of Hospitalized Non-alcoholic Fatty Liver Disease: A 10 Years' Cross-Sectional Multicenter Study in China. Frontiers in Medicine. 7. 584396–584396. 20 indexed citations
13.
Ye, Junzhao, Congxiang Shao, Fuxi Li, et al.. (2021). Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease. Frontiers in Endocrinology. 12. 691556–691556. 12 indexed citations
14.
Ye, Junzhao, Yang Huang, Yanhong Sun, et al.. (2021). Dynamic monitoring with shear wave elastography predicts outcomes of chronic hepatitis B patients with decompensated cirrhosis. Annals of Translational Medicine. 9(21). 1613–1613. 5 indexed citations
15.
Li, Fuxi, Junzhao Ye, Congxiang Shao, & Bihui Zhong. (2021). Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis. Lipids in Health and Disease. 20(1). 22–22. 84 indexed citations
16.
Chen, Jiansong, Yue Hu, Congxiang Shao, Haiyun Zhou, & Zhiyue Lv. (2021). The Imprinted PARAFILM as a New Carrier Material for Dried Plasma Spots (DPSs) Utilizing Desorption Electrospray Ionization Mass Spectrometry (DESI-MS) in Phospholipidomics. Frontiers in Chemistry. 9. 801043–801043. 1 indexed citations
17.
Li, Fuxi, Junzhao Ye, Yanhong Sun, et al.. (2021). Distinct Dose-Dependent Association of Free Fatty Acids with Diabetes Development in Nonalcoholic Fatty Liver Disease Patients. Diabetes & Metabolism Journal. 45(3). 417–429. 17 indexed citations
18.
Shao, Congxiang, Junzhao Ye, Fuxi Li, et al.. (2019). Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease. Digestive and Liver Disease. 51(10). 1392–1399. 31 indexed citations
19.
Ye, Junzhao, Yanqin Wu, Congxiang Shao, et al.. (2019). Insulin resistance exhibits varied metabolic abnormalities in nonalcoholic fatty liver disease, chronic hepatitis B and the combination of the two: a cross-sectional study. Diabetology & Metabolic Syndrome. 11(1). 45–45. 17 indexed citations
20.
Shao, Congxiang, Junzhao Ye, Fuxi Li, et al.. (2019). Early Predictors of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease: Non-obese Versus Obese Patients. Digestive Diseases and Sciences. 65(6). 1850–1860. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bihui Zhong Breakdown of academic impact, for papers by Marta Flisiak‐Jackiewicz Breakdown of academic impact, for papers by Erika Paolini Breakdown of academic impact, for papers by Luis Miguel Vazquez‐Montesino Breakdown of academic impact, for papers by Cristina Muzîca Breakdown of academic impact, for papers by Silvia Sabatini Breakdown of academic impact, for papers by Jacob George Breakdown of academic impact, for papers by Mary P. Moore Breakdown of academic impact, for papers by Kristina Önnerhag Breakdown of academic impact, for papers by Mauro Maurantonio
Rankless by CCL
2026